TenSixteen Bio is a San Francisco-based clinical-stage biotechnology company pioneering the study of somatic mosaicism and clonal hematopoiesis of indeterminate potential (CHIP) to discover and develop novel therapeutics for age-related diseases including cancer and cardiovascular disease. - View it on GitHub